ESC 365 - The prevalence and accumulation of main cardiometabolic risk factors among the finnish adult population at different levels of lp(a)

Delegates Premium Access

The prevalence and accumulation of main cardiometabolic risk factors among the finnish adult population at different levels of lp(a)

Session: Dyslipidaemia management in 2025: status quo and best practice (1)

Topic: Cardiovascular Risk Assessment

Speaker: Professor P. Jousilahti (Helsinki, FI)

Event: ESC Preventive Cardiology 2025

Congress Presentation

Add to my library

About the speaker

Professor Pekka Jousilahti

Finnish Institute for Health and Welfare (THL), Helsinki (Finland)

0 follower

4 more presentations in this session

Does the length of evolocumab use contribute to myocardial infarction associated hospital readmissions in patients with ACS?: a single center real world evidence from ELAINE

Speaker: Doctor O. Wani (Flagstaff, US)

Statin intolerance in a real word setting of Italian cardiology centers: data from the BRING-UP Prevention study

Speaker: Doctor S. Di Fusco (Rome, IT)

Deficient perceptions and practices concerning elevated lipoprotein(a) among specialists in Singapore

Speaker: Doctor W. Loh (Singapore, SG)

A collaborative working project in primary care: optimising lipid lowering therapies for secondary prevention in high risk patients

Speaker: Doctor J. Ward (Westbury, GB)

Access the full session

Dyslipidaemia management in 2025: status quo and best practice (1)

Speakers: Professor P. Jousilahti, Doctor O. Wani, Doctor S. Di Fusco, Doctor W. Loh, Doctor J. Ward

About the event

ESC Preventive Cardiology 2025

3 April - 5 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources